AbbVie Lowers Full-Year Profit Guidance, Investor Disappointment Triggers Stock Sell-Off Aug 1, 2026 Life Science
Bristol-Myers Squibb Beats Estimates in Q2, Stock Outperforms Market on Thursday Jul 31, 2026 Life Science
Seize the Golden Window for Biotech IPOs, Attovia Aims to Raise Up to $212.5 Million in Nasdaq Debut Jul 29, 2026 Life Science
Johnson & Johnson Quietly Completes Strategic Pivot, Targeting $50 Billion Cancer Drug Blueprint Jul 29, 2026 Life Science
Moderna’s Market Value Exceeds Twenty Billion Dollars, Yet Ongoing Operating Losses and Competitive Pressures Continue to Trouble Investors Jul 27, 2026 Life Science
AbbVie Outperforms S&P 500 This Year, With Three Major Long-Term Positive Factors Supporting Future Performance Jul 22, 2026 Life Science
Anti-Cancer Upstart’s Stock Surges 125% This Year as Billionaire Druckenmiller Builds Large Position Jul 18, 2026 Life Science
Raising Dividends for 54 Consecutive Years to Reward Shareholders, Abbott Laboratories’ Diversified Layout Consolidates Its Growth Foundation Jul 17, 2026 Life Science
UnitedHealth Group Stock Rises 37% Year-to-Date, Market Sees Path Back to All-Time Highs Jul 16, 2026 Life Science
The Market Has Responded Coolly to Vertex’s Multibillion-Dollar Acquisition, but Management’s Track Record and Integration Capabilities Add Confidence to the Deal Jul 14, 2026 Life Science
Core Business Steady Growth Coupled with Acquisition Tailwinds, Vertex Pharmaceuticals Demonstrates Strong Post-Market Momentum Jul 11, 2026 Life Science
Incyte and TG Therapeutics Deliver Notable Growth, Drawing Investment Attention to the Biotech Sector Jul 9, 2026 Life Science
Two Healthcare Blue-Chip Stocks Offer Opportunities as Dividends Shine Bright for Pfizer and Bristol-Myers Squibb Jul 8, 2026 Life Science
Biotech Double Winners Outperform the Market, With Fundamental Tailwinds Poised to Sustain Momentum Jul 7, 2026 Life Science
Eli Lilly Stock Hits Record High as Analysts Bullish on Weight-Loss Drug Market Prospects Jul 7, 2026 Life Science
The $10 Billion Acquisition Is Set, as Vertex Pharmaceuticals Bets on a New Blue Ocean in Rare Endocrine Diseases Jul 7, 2026 Life Science
TransMedics Is Betting on Kidney Transplants and European Expansion Despite a 40% Stock Drop in Six Months, Yet Long-Term Prospects Remain Strong Jul 4, 2026 Life Science
